Cancer-related secondary lymphoedema due to cutaneous lymphangitis carcinomatosa: clinical presentations and review of literature.
Identifieur interne : 002C32 ( PubMed/Curation ); précédent : 002C31; suivant : 002C33Cancer-related secondary lymphoedema due to cutaneous lymphangitis carcinomatosa: clinical presentations and review of literature.
Auteurs : R J Damstra [Pays-Bas] ; E A Jagtman ; P M SteijlenSource :
- European journal of cancer care [ 1365-2354 ] ; 2010.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Carcinomes (), Carcinomes (traitement médicamenteux), Femelle, Humains, Lymphangite (), Lymphangite (anatomopathologie), Lymphangite (physiopathologie), Lymphoedème (étiologie), Mâle, Résultat thérapeutique, Sujet âgé, Système lymphatique (anatomopathologie), Système lymphatique (physiopathologie), Tumeurs (), Tumeurs (traitement médicamenteux).
- MESH :
- anatomopathologie : Lymphangite, Système lymphatique.
- physiopathologie : Lymphangite, Système lymphatique.
- traitement médicamenteux : Carcinomes, Tumeurs.
- étiologie : Lymphoedème.
- Adulte d'âge moyen, Carcinomes, Femelle, Humains, Lymphangite, Mâle, Résultat thérapeutique, Sujet âgé, Tumeurs.
English descriptors
- KwdEn :
- Aged, Carcinoma (complications), Carcinoma (drug therapy), Female, Humans, Lymphangitis (complications), Lymphangitis (pathology), Lymphangitis (physiopathology), Lymphatic System (pathology), Lymphatic System (physiopathology), Lymphedema (etiology), Male, Middle Aged, Neoplasms (complications), Neoplasms (drug therapy), Treatment Outcome.
- MESH :
- complications : Carcinoma, Lymphangitis, Neoplasms.
- drug therapy : Carcinoma, Neoplasms.
- etiology : Lymphedema.
- pathology : Lymphangitis, Lymphatic System.
- physiopathology : Lymphangitis, Lymphatic System.
- Aged, Female, Humans, Male, Middle Aged, Treatment Outcome.
Abstract
Lymphoedema is a clinical condition caused by impairment of the lymphatic system, leading to swelling of subcutaneous soft tissues. As a result, accumulation of protein-rich interstitial fluid and lymphostasis often causes additional swelling, fibrosis and adipose tissue hypertrophy leading to progressive morbidity and loss of quality of life for the patient. Lymphoedema can be distinguished as primary or secondary. Lymphoedema is a complication frequently encountered in patients treated for cancer, especially after lymphadenoectomy and/or radiotherapy based on destruction of lymphatics. However, although lymphatic impairment is sometimes caused by obstructive solid metastasis, we present three cases of secondary lymphoedema with minor dermatological features without detectable solid metastasis. Sometimes this type of lymphoedema is mistakenly called malignant lymphoedema. All patients were previously treated for cancer without clinical signs of recurrence, presented with progressive lymphoedema and minor dermatological features of unknown origin. Clinical and histopathological examination of the skin revealed diffuse lymphangitis carcinomatosa, leading to secondary lymphoedema and adjustment of the therapeutic approach and prognosis. We reviewed literature on these rare presentations of cancer recurrence and recommend, where appropriate, consulting a dermatologist when discrete skin abnormalities are seen in patients with a history of cancer and developing lymphoedema.
DOI: 10.1111/j.1365-2354.2009.01102.x
PubMed: 20030691
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002C32
Links to Exploration step
pubmed:20030691Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cancer-related secondary lymphoedema due to cutaneous lymphangitis carcinomatosa: clinical presentations and review of literature.</title><author><name sortKey="Damstra, R J" sort="Damstra, R J" uniqKey="Damstra R" first="R J" last="Damstra">R J Damstra</name><affiliation wicri:level="1"><nlm:affiliation>Nij Smellinghe Hospital, Department of Dermatology and Phlebology and Lymphology, Compagnonsplein, Drachten, the Netherlands. r.damstra@nijsmellinghe.nl</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Nij Smellinghe Hospital, Department of Dermatology and Phlebology and Lymphology, Compagnonsplein, Drachten</wicri:regionArea></affiliation></author><author><name sortKey="Jagtman, E A" sort="Jagtman, E A" uniqKey="Jagtman E" first="E A" last="Jagtman">E A Jagtman</name></author><author><name sortKey="Steijlen, P M" sort="Steijlen, P M" uniqKey="Steijlen P" first="P M" last="Steijlen">P M Steijlen</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2010">2010</date><idno type="RBID">pubmed:20030691</idno><idno type="pmid">20030691</idno><idno type="doi">10.1111/j.1365-2354.2009.01102.x</idno><idno type="wicri:Area/PubMed/Corpus">002C32</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002C32</idno><idno type="wicri:Area/PubMed/Curation">002C32</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002C32</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Cancer-related secondary lymphoedema due to cutaneous lymphangitis carcinomatosa: clinical presentations and review of literature.</title><author><name sortKey="Damstra, R J" sort="Damstra, R J" uniqKey="Damstra R" first="R J" last="Damstra">R J Damstra</name><affiliation wicri:level="1"><nlm:affiliation>Nij Smellinghe Hospital, Department of Dermatology and Phlebology and Lymphology, Compagnonsplein, Drachten, the Netherlands. r.damstra@nijsmellinghe.nl</nlm:affiliation><country xml:lang="fr" wicri:curation="lc">Pays-Bas</country><wicri:regionArea>Nij Smellinghe Hospital, Department of Dermatology and Phlebology and Lymphology, Compagnonsplein, Drachten</wicri:regionArea></affiliation></author><author><name sortKey="Jagtman, E A" sort="Jagtman, E A" uniqKey="Jagtman E" first="E A" last="Jagtman">E A Jagtman</name></author><author><name sortKey="Steijlen, P M" sort="Steijlen, P M" uniqKey="Steijlen P" first="P M" last="Steijlen">P M Steijlen</name></author></analytic><series><title level="j">European journal of cancer care</title><idno type="eISSN">1365-2354</idno><imprint><date when="2010" type="published">2010</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Carcinoma (complications)</term><term>Carcinoma (drug therapy)</term><term>Female</term><term>Humans</term><term>Lymphangitis (complications)</term><term>Lymphangitis (pathology)</term><term>Lymphangitis (physiopathology)</term><term>Lymphatic System (pathology)</term><term>Lymphatic System (physiopathology)</term><term>Lymphedema (etiology)</term><term>Male</term><term>Middle Aged</term><term>Neoplasms (complications)</term><term>Neoplasms (drug therapy)</term><term>Treatment Outcome</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Carcinomes ()</term><term>Carcinomes (traitement médicamenteux)</term><term>Femelle</term><term>Humains</term><term>Lymphangite ()</term><term>Lymphangite (anatomopathologie)</term><term>Lymphangite (physiopathologie)</term><term>Lymphoedème (étiologie)</term><term>Mâle</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Système lymphatique (anatomopathologie)</term><term>Système lymphatique (physiopathologie)</term><term>Tumeurs ()</term><term>Tumeurs (traitement médicamenteux)</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Lymphangite</term><term>Système lymphatique</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Carcinoma</term><term>Lymphangitis</term><term>Neoplasms</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Carcinoma</term><term>Neoplasms</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Lymphangitis</term><term>Lymphatic System</term></keywords><keywords scheme="MESH" qualifier="physiopathologie" xml:lang="fr"><term>Lymphangite</term><term>Système lymphatique</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Lymphangitis</term><term>Lymphatic System</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Carcinomes</term><term>Tumeurs</term></keywords><keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lymphoedème</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Treatment Outcome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Carcinomes</term><term>Femelle</term><term>Humains</term><term>Lymphangite</term><term>Mâle</term><term>Résultat thérapeutique</term><term>Sujet âgé</term><term>Tumeurs</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Lymphoedema is a clinical condition caused by impairment of the lymphatic system, leading to swelling of subcutaneous soft tissues. As a result, accumulation of protein-rich interstitial fluid and lymphostasis often causes additional swelling, fibrosis and adipose tissue hypertrophy leading to progressive morbidity and loss of quality of life for the patient. Lymphoedema can be distinguished as primary or secondary. Lymphoedema is a complication frequently encountered in patients treated for cancer, especially after lymphadenoectomy and/or radiotherapy based on destruction of lymphatics. However, although lymphatic impairment is sometimes caused by obstructive solid metastasis, we present three cases of secondary lymphoedema with minor dermatological features without detectable solid metastasis. Sometimes this type of lymphoedema is mistakenly called malignant lymphoedema. All patients were previously treated for cancer without clinical signs of recurrence, presented with progressive lymphoedema and minor dermatological features of unknown origin. Clinical and histopathological examination of the skin revealed diffuse lymphangitis carcinomatosa, leading to secondary lymphoedema and adjustment of the therapeutic approach and prognosis. We reviewed literature on these rare presentations of cancer recurrence and recommend, where appropriate, consulting a dermatologist when discrete skin abnormalities are seen in patients with a history of cancer and developing lymphoedema.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">20030691</PMID><DateCreated><Year>2010</Year><Month>08</Month><Day>25</Day></DateCreated><DateCompleted><Year>2011</Year><Month>04</Month><Day>01</Day></DateCompleted><DateRevised><Year>2010</Year><Month>08</Month><Day>25</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1365-2354</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>5</Issue><PubDate><Year>2010</Year><Month>Sep</Month></PubDate></JournalIssue><Title>European journal of cancer care</Title><ISOAbbreviation>Eur J Cancer Care (Engl)</ISOAbbreviation></Journal><ArticleTitle>Cancer-related secondary lymphoedema due to cutaneous lymphangitis carcinomatosa: clinical presentations and review of literature.</ArticleTitle><Pagination><MedlinePgn>669-75</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/j.1365-2354.2009.01102.x</ELocationID><Abstract><AbstractText>Lymphoedema is a clinical condition caused by impairment of the lymphatic system, leading to swelling of subcutaneous soft tissues. As a result, accumulation of protein-rich interstitial fluid and lymphostasis often causes additional swelling, fibrosis and adipose tissue hypertrophy leading to progressive morbidity and loss of quality of life for the patient. Lymphoedema can be distinguished as primary or secondary. Lymphoedema is a complication frequently encountered in patients treated for cancer, especially after lymphadenoectomy and/or radiotherapy based on destruction of lymphatics. However, although lymphatic impairment is sometimes caused by obstructive solid metastasis, we present three cases of secondary lymphoedema with minor dermatological features without detectable solid metastasis. Sometimes this type of lymphoedema is mistakenly called malignant lymphoedema. All patients were previously treated for cancer without clinical signs of recurrence, presented with progressive lymphoedema and minor dermatological features of unknown origin. Clinical and histopathological examination of the skin revealed diffuse lymphangitis carcinomatosa, leading to secondary lymphoedema and adjustment of the therapeutic approach and prognosis. We reviewed literature on these rare presentations of cancer recurrence and recommend, where appropriate, consulting a dermatologist when discrete skin abnormalities are seen in patients with a history of cancer and developing lymphoedema.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Damstra</LastName><ForeName>R J</ForeName><Initials>RJ</Initials><AffiliationInfo><Affiliation>Nij Smellinghe Hospital, Department of Dermatology and Phlebology and Lymphology, Compagnonsplein, Drachten, the Netherlands. r.damstra@nijsmellinghe.nl</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jagtman</LastName><ForeName>E A</ForeName><Initials>EA</Initials></Author><Author ValidYN="Y"><LastName>Steijlen</LastName><ForeName>P M</ForeName><Initials>PM</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2009</Year><Month>12</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Eur J Cancer Care (Engl)</MedlineTA><NlmUniqueID>9301979</NlmUniqueID><ISSNLinking>0961-5423</ISSNLinking></MedlineJournalInfo><CitationSubset>N</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002277" MajorTopicYN="N">Carcinoma</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008205" MajorTopicYN="N">Lymphangitis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="N">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008208" MajorTopicYN="N">Lymphatic System</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName><QualifierName UI="Q000503" MajorTopicYN="Y">physiopathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2009</Year><Month>12</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2011</Year><Month>4</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">20030691</ArticleId><ArticleId IdType="pii">ECC1102</ArticleId><ArticleId IdType="doi">10.1111/j.1365-2354.2009.01102.x</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002C32 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 002C32 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:20030691
|texte= Cancer-related secondary lymphoedema due to cutaneous lymphangitis carcinomatosa: clinical presentations and review of literature.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:20030691" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |